RT
November 13, 2021
Russian authorities have registered an intravenous solution to treat Covid-19, TASS news agency reports, citing the developers. The manufacturer says the remedy is designed to directly fight the coronavirus.
Dubbed Areplivir, the “first direct-acting intravenous solution for treatment of Covid-19 in Russia” has been registered by the authorities, its developer Promomed told TASS on Friday. The company added that the drug would be available for use in hospitals before year’s end.
The solution is a new form of the drug that has been used in Russia as pills since September 2020. It is based on the synthetic drug favipiravir, registered in neighboring Japan to treat influenza, and being actively studied as potential anti-Covid medication.